article thumbnail

Episode 864: Why Did ISMP Remove the Do Not Crush List from Their Website?

Pharmacy Joe

Subscribe on iTunes , Android , or Stitcher If you navigate to the page on the website for the Institute for Safe Medication Practices that once hosted the document titled “Oral Dosage Forms That Should Not Be Crushed” you will instead find a notice that the list has been removed from the ISMP website.

Dosage 111
article thumbnail

Episode 864: Why Did ISMP Remove the Do Not Crush List from Their Website?

Pharmacy Joe

Subscribe on iTunes , Android , or Stitcher If you navigate to the page on the website for the Institute for Safe Medication Practices that once hosted the document titled “Oral Dosage Forms That Should Not Be Crushed” you will instead find a notice that the list has been removed from the ISMP website.

Dosage 52
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Securing every dose with an edible security technology for safe medicines

European Pharmaceutical Review

On- or in-dose authentication means that a security measure or anticounterfeit feature is integrated with the dosage form itself, offering product verification and traceability embedded into each medicine, rather than on the secondary package” WHO estimates that >50 percent of the drugs for sale on the internet are fake. References.

Dosage 88
article thumbnail

2022 spells change for EU pharmaceutical legislation

European Pharmaceutical Review

Regulation (EC) No 1901/2006 of the European Parliament and of the Council of 12 December 2006 on medicinal products for paediatric use and amending Regulation (EEC) No 1768/92, Directive 2001/20/EC, Directive 2001/83/EC and Regulation (EC) No 726/2004 (Text with EEA relevance). Future outlook. Amsterdam: Gupta Strategists; 2019.

article thumbnail

Thirty years of the Patented Medicines (Notice of Compliance) Regulations

Pharma in Brief

5] This provision was replaced in 1998, and further amended in 2006 to confirm that generic and biosimilar manufacturers could not seek a disgorgement of innovators’ profits instead of their own damages. The original version of section 8 proved “particularly obscure in its meaning”. [5] Frozen” register.

article thumbnail

Menopause

RX Note

External Links Therapeutic Guidelines - Overview of Menopause Management of menopause, 2023 Nonhormonal therapies for menopausal hot flashes: systematic review and meta-analysis, 2006 The effect of dietary soy supplementation compared to estrogen and placebo on menopausal symptoms: a randomized controlled trial, 2010 Pooled Analysis of Six Pharmacologic (..)

Dosage 52
article thumbnail

Federal Court refuses to issue injunction on infringed antibody formulation patent

Pharma in Brief

The Court also found that two other patents, which cover dosage regimens and new uses of adalimumab, are invalid for obviousness. The Court found: Anticipation: The claims at issue were not anticipated by WO 2006/138181. with either no pH-buffering system or a low ionic strength ( i.e. , conductivity of less than 2.5